Literature DB >> 2175343

Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias.

L Longo1, P P Pandolfi, A Biondi, A Rambaldi, A Mencarelli, F Lo Coco, D Diverio, L Pegoraro, G Avanzi, A Tabilio.   

Abstract

Although acute promyelocytic leukemias (APLs) are consistently associated with a reciprocal chromosome 15;17 translocation, the gene(s) directly affected by the breakpoints have never been isolated. The chromosome 17 breakpoint maps to near the retinoic acid receptor alpha (RAR alpha) locus. Investigation of 20 APLs and a large series of other neoplastic patients and normal controls revealed RAR alpha gene rearrangements and aberrant transcripts only in the APL cases. These findings suggest that the RAR alpha gene is involved in the APL chromosome 17 breakpoint, is implicated in leukemogenesis, and could be used as a marker for identifying leukemic promyelocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175343      PMCID: PMC2188762          DOI: 10.1084/jem.172.6.1571

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  Mapping of the human retinoic acid receptor to the q21 band of chromosome 17.

Authors:  M G Mattei; M Petkovich; J F Mattei; N Brand; P Chambon
Journal:  Hum Genet       Date:  1988-10       Impact factor: 4.132

2.  Identification of a receptor for the morphogen retinoic acid.

Authors:  V Giguere; E S Ong; P Segui; R M Evans
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

3.  Relationship between blast-cell morphology and occurrence of a syndrome of disseminated intravascular coagulation.

Authors:  C Sultan; M Heilmann-Gouault; M Tulliez
Journal:  Br J Haematol       Date:  1973-02       Impact factor: 6.998

4.  15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia.

Authors:  J D Rowley; H M Golomb; C Dougherty
Journal:  Lancet       Date:  1977-03-05       Impact factor: 79.321

5.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.

Authors:  M E Huang; Y C Ye; S R Chen; J R Chai; J X Lu; L Zhoa; L J Gu; Z Y Wang
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

6.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

7.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.

Authors:  T R Breitman; S E Selonick; S J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

Review 8.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

9.  Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes.

Authors:  H de The; A Marchio; P Tiollais; A Dejean
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

10.  C-abl and bcr are rearranged in a Ph1-negative CML patient.

Authors:  C R Bartram; E Kleihauer; A de Klein; G Grosveld; J R Teyssier; N Heisterkamp; J Groffen
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

View more
  36 in total

1.  CD2+ tetraploid acute promyelocytic leukemia variant with double (15;17) translocations.

Authors:  Ken Kaito; Hiroko Otsubo; Nobuaki Dobashi; Noriko Usui; Masayuki Kobayashi
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

Review 2.  Leukaemogenesis: more than mutant genes.

Authors:  Jianjun Chen; Olatoyosi Odenike; Janet D Rowley
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

Review 3.  Detection of minimal residual disease in multiple myeloma and acute leukaemia.

Authors:  M H Bakkus; N Juge-Morineau; J E van der Werff ten Bosch
Journal:  Med Oncol       Date:  1996-06       Impact factor: 3.064

Review 4.  Transcriptional regulation during myelopoiesis.

Authors:  N Lenny; J J Westendorf; S W Hiebert
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

5.  All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells.

Authors:  C Chomienne; N Balitrand; P Ballerini; S Castaigne; H de Thé; L Degos
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

6.  Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body.

Authors:  V J LaMorte; J A Dyck; R L Ochs; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

7.  Acute promyelocytic leukaemia with hypogranular bone marrow blasts in a 16-year-old girl: diagnostic value of different genetic methods.

Authors:  W Scherulen; J Harbott; J W Janssen; J Kühl; C R Bartram
Journal:  Eur J Pediatr       Date:  1995-05       Impact factor: 3.183

8.  Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor alpha locus.

Authors:  M Alcalay; D Zangrilli; P P Pandolfi; L Longo; A Mencarelli; A Giacomucci; M Rocchi; A Biondi; A Rambaldi; F Lo Coco
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

9.  PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors.

Authors:  Z Chen; F Guidez; P Rousselot; A Agadir; S J Chen; Z Y Wang; L Degos; A Zelent; S Waxman; C Chomienne
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

10.  Pulsed-field gel electrophoresis analysis of retinoic acid receptor-alpha and promyelocytic leukemia rearrangements. Detection of the t(15;17) translocation in the diagnosis of acute promyelocytic leukemia.

Authors:  Y H Xiao; W H Miller; R P Warrell; E Dmitrovsky; A D Zelenetz
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.